CLX

Analyst Note: CLX (The Clorox Company)

Date: 2026-06-13 Current Price: $95.80

1. Structural Readiness

• State: Context-Only (Forming Coil)
• Conservative Entry: Not yet defined (requires confirmed breakout).
• Aggressive/Pre-Breakout Entry: N/A (Setup is in the forming phase; entry is not actionable on setup alone).
• Breakout Level: Not yet defined.
• Current Price: $95.80.
• Extension: N/A (Price is within the consolidation range, not extended above a breakout level).
• ATR Context: Current ATR is 3.1% (productive). This sits within the historical "productive" range, suggesting manageable volatility for position sizing once a setup is confirmed, though it is below the 4–6% "sweet spot" for high-momentum breakouts.
• Classification: The setup is FORMING. This is a partial signal. The structure is in place, and price is holding above the implied support, but the catalyst (breakout) has not fired. It is not invalidated.

2. Thesis Layer

• Thesis Status: TACTICAL / Setup-Led.
• Macro Thesis: There is no named secular thesis attached to this setup as of 2026-06-13.
• Judgment Framework: The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the immediate business fundamentals (margin inflection, integration progress) rather than a broad macro narrative. Do not invent a thesis; the conviction rests on the execution of the "Margin Inflector" archetype.

3. Business Overview

The Clorox Company is a leading multinational manufacturer and marketer of consumer and professional products, operating through four segments: Health and Wellness, Household, Lifestyle, and International.

• Scale & Reach: As of the latest reporting (2026-04-30), the company employs approximately 7,600 people and operates in roughly 25 countries, selling in 100 markets. Approximately 80% of sales come from brands holding the No. 1 or No. 2 market share position in their categories (Evidence E11, E15).
• Recent Strategic Moves:
• GOJO Acquisition: The company closed the acquisition of GOJO Industries, Inc. on April 1, 2026. This $800 million business adds growth exposure in health and hygiene, with management expecting it to contribute $200 million in Q4 2026 (approx. 10% of the quarter's revenue) and the remainder in fiscal 2027 (Evidence E5, E6).
• Glad Venture: On March 2, 2026, Clorox purchased P&G's 20% interest in the Glad bags and wraps venture for $476 million, gaining full control of the brand (Evidence E8, E9).
• Operational Status:
• ERP Implementation: The company announced the completion of its ERP implementation as of April 2026, positioning the firm to convert innovation and distribution gains into value (Evidence E1).
• Retail Reset: Management notes that retailers are still resetting shelves and will continue to do so through the remainder of Q4, expecting continued progress (Evidence E2).
• Category Performance: Through Q3, aggregate category performance was flat to up 1%, aligning with initial expectations (Evidence E7).
• Financial Headwinds: For Q4, management assumes a crude oil midpoint of $100 per barrel, projecting $20–$25 million in headwinds (approx. 130 basis points of gross margin) (Evidence E3).
• Customer Concentration: Walmart remains the largest customer, accounting for 26% of consolidated net sales in fiscal 2025 (Evidence E16).

4. Archetype and Conviction

• Archetype: Margin Inflector.
• Fit: The setup aligns with the "Margin Inflector" archetype due to the completion of the ERP system (E1), the full integration of the Glad business (E8), and the strategic acquisition of GOJO (E5). These actions are designed to streamline operations and improve margins post-implementation.
• Valuation Context: The financial spine indicates a forward consensus EPS of $5.53 for FY1 and $6.22 for FY2 (Evidence E31).
• Conviction Stack:
• Thesis Strength: Low (Tactical only; no macro tailwind).
• Evidence Quality: High. Recent earnings (April 2026) and SEC filings provide clear data on the GOJO integration, ERP completion, and specific margin headwinds.
• Rerating Potential: Dependent on the successful execution of the "Margin Inflector" thesis—specifically, whether the ERP and GOJO integration can offset the $100/barrel oil headwinds and the inventory drawdown from the previous year's retailer pre-ordering (Evidence E17).

5. Invalidations, Strengtheners, and Gaps

• Strengtheners: A confirmed breakout above the resistance level (firing the coil) would confirm the setup. Continued progress on the retailer shelf reset (E2) and successful offsetting of the $100/barrel oil headwinds would strengthen the fundamental case.
• Gaps in Evidence:
• Q2/Q3 2026 Detailed Financials: While Q3 category performance is mentioned, specific Q2/Q3 2026 revenue and margin numbers are not detailed in the provided text, only the Q4 outlook and FY2026 guidance.
• Debt Refinancing Status: While the company plans to refinance GOJO borrowings (E13), the specific terms or success of this refinancing as of June 13, 2026, are not detailed.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: ERP implementation complete and GOJO acquisition closed with clear integration progress; 80% of sales from No. 1/2 market share brands; forward EPS growth projected to FY2. Key risks: $100/barrel oil assumption creating 130 bps gross margin headwinds; retailer inventory drawdown reversing prior ERP-related sales benefits; Walmart concentration at 26% of sales. Sizing hint: Position size should be conservative until the forming coil fires a confirmed breakout; current volatility (3.1% ATR) allows for standard sizing if entry is taken on breakout. Expected path: Management expects continued progress on retailer shelf resets through Q4 and full integration of GOJO in FY27; the stock likely consolidates as the market digests the ERP completion and M&A impact before a directional move. Expected horizon: 3 to 6 months for the forming coil to resolve into a confirmed breakout or invalidation.